Triad warfare against biofilms: disrupting quorum sensing, nanotechnology-driven precision, and host immunomodulation to conquer antimicrobial resistance
Archives of Microbiology · 2026-05 · 208 (5)
DOI: 10.1007/s00203-026-04750-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Microbiology, online erschienen am 23.02.2026. Verfasst von Hamza M A Eid und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Madinah, 42353, Saudi Arabia. Hauptthemen laut MEDLINE: Quorum Sensing, Biofilms, Anti-Bacterial Agents, Immunomodulation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 220 Literaturangaben.
Abstract (Originalsprache)
Biofilm-associated infections pose a major global health threat due to their inherent resistance to conventional antibiotics, mediated by quorum sensing (QS), extracellular polymeric substances (EPS), persister cells, and immune evasion mechanisms. In this review, we propose the “Triad Warfare” strategy, integrating quorum-sensing inhibition (QSI), nanotechnology-enabled targeted drug delivery, and host-directed immunomodulation to synergistically disrupt biofilms while minimizing the risk of antimicrobial resistance (AMR). Specifically, QSI-mediated EPS disruption enhances nanoparticle penetration, facilitating controlled release of antimicrobial agents, while immunomodulators potentiate macrophage and neutrophil activity to clear residual bacterial populations, including metabolically dormant persisters. We provide a comparative analysis of natural and synthetic QS inhibitors, surface-modified nanoparticles (e.g., PEGylated AgNPs), and immunotherapeutic approaches (macrophage polarization, NET modulation, cytokine delivery), highlighting their efficacy, translational challenges, and clinical trial updates (Phase 1–2). Recent metabolic stimulation strategies (e.g., mannitol with aminoglycosides) and CRISPR-guided antimicrobials are also discussed for persister eradication. Furthermore, AI-driven anti-biofilm drug discovery using datasets such as AntiBiofilmDB, ChEMBL, and PubChem is evaluated for predictive design of combinatorial therapeutics. Collectively, this review emphasizes the mechanistic synergy, translational feasibility, and adaptive optimization of the triad approach, providing a roadmap for the development of next-generation anti-biofilm therapies with minimized resistance potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Madinah, 42353, Saudi Arabia.
- Institute of Biotechnology & Genetic Engineering (Health Division), The University of Agriculture Peshawar, Peshawar, 25130, Pakistan. najeebkhan@aup.edu.pk.
Zitieren
APA
Eid, H. M. A., Almutawif, Y. A., & Khan, N. U. (2026). Triad warfare against biofilms: disrupting quorum sensing, nanotechnology-driven precision, and host immunomodulation to conquer antimicrobial resistance. Archives of Microbiology, 208(5). https://doi.org/10.1007/s00203-026-04750-8
Vancouver
Eid HMA, Almutawif YA, Khan NU. Triad warfare against biofilms: disrupting quorum sensing, nanotechnology-driven precision, and host immunomodulation to conquer antimicrobial resistance. Archives of Microbiology. 2026;208(5). doi:10.1007/s00203-026-04750-8
BibTeX
@article{Eid2026,
author = {Eid, Hamza M A and Almutawif, Yahya A and Khan, Najeeb Ullah},
title = {Triad warfare against biofilms: disrupting quorum sensing, nanotechnology-driven precision, and host immunomodulation to conquer antimicrobial resistance},
journal = {Archives of Microbiology},
year = {2026},
volume = {208},
number = {5},
doi = {10.1007/s00203-026-04750-8}
}
EUVIMED